Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-carnitine + N-acetyl cysteine is a combination of two amino acid-derived compounds commonly used as dietary supplements. L-carnitine (often in the form of acetyl-L-carnitine) plays a key role in mitochondrial energy production by facilitating the transport of fatty acids into mitochondria for beta-oxidation. N-acetyl cysteine (NAC) is a precursor to glutathione, an important intracellular antioxidant, and has additional roles as an anti-inflammatory and mucolytic agent. The combination has been studied for its synergistic antioxidant effects, neuroprotection, enhancement of DNA repair mechanisms after cellular stress such as radiation exposure[1][3], support for mitochondrial function and energy metabolism[2], improvement in metabolic parameters including insulin sensitivity[4], and potential benefits in neurological disorders. Both components can cross the blood-brain barrier and may modulate neurotransmitter systems including glutamate balance and acetylcholine levels[2]. The mixture is primarily marketed as a dietary supplement but individual components have pharmaceutical uses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-carnitine + N-acetyl cysteine.